CCLDO — Stock Film
STOCK FILMSCENE 1/12CCLDO · $27.44
Stock Expert AI presents
CCLDO
CareCloud, Inc
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
CareCloud, Inc. What it actually does.

Provide cloud-based healthcare IT solutions to healthcare providers and hospitals. Offer a comprehensive Software-as-a-Service platform for revenue cycle management. Now — the numbers.

on the stock market since 2022
3,650 employees
$857.3M market value
WHERE DOES THE MONEY COME FROM?
80%Revenue Cycle Management
Revenue Cycle ManagementRemote Patient Monitoring 20%
80% of all revenue comes from a single line: Revenue Cycle Management.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$120.5M
The net profit left over:
$10.8M
Out of every $100 in sales, $9 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 9%

This is an established company with proven profits.

THE SALES TREND
Sales have been shrinking.

An average decline of 4% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$139.6M
2021
2022
2023
2024
$120.5M
2025
Cash on hand:
$3.1M
Total debt:
$4.3M
The debt outweighs the cash.

The gap is $1.2M. In times of high interest rates, a gap like that can squeeze a company.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
79.4×

The market pays 79.4× for every dollar this company earns in a year — a price that already assumes things go well.

No analyst target is on record for this company.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Thin trading in the shares2/10
Sales are shrinking4/10
WORTH WATCHING

Trading Liquidity: The shares change hands too rarely for smooth trading.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/1
Pays a steady dividend

It pays out $4.82 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Sales are shrinking

Over the last 4 years, sales fell about 4% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/2
A rich price tag

The company’s market value is 79 times its annual profit. Even a small disappointment could hit the price hard.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film